105 related articles for article (PubMed ID: 10022539)
1. Gene therapy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol.
Wollenberg B; Kastenbauer ; Mundl H; Schaumberg J; Mayer A; Andratschke M; Lang S; Pauli C; Zeidler R; Ihrler S; Löhrs ; Naujoks K; Rollston R
Hum Gene Ther; 1999 Jan; 10(1):141-7. PubMed ID: 10022539
[TBL] [Abstract][Full Text] [Related]
2. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
3. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
[TBL] [Abstract][Full Text] [Related]
4. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model].
Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865
[TBL] [Abstract][Full Text] [Related]
5. Liposomal transfection of squamous carcinoma cells of the head and neck with IL-2 and B7 plasmids inducing an autologous immune response in vitro.
Mayer A; Andratschke M; Pauli C; Reitberger E; Kolbow K; Wollenberg B
Anticancer Res; 2005; 25(6B):3917-23. PubMed ID: 16309178
[TBL] [Abstract][Full Text] [Related]
6. [Antitumour study with combined IL-2 gene therapy and radiation for head and neck squamous cell carcinoma].
Liu S; Yang H; Tang Z; Liang C
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 17(2):105-7. PubMed ID: 12833697
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
8. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma.
Li D; Shugert E; Guo M; Bishop JS; O'Malley BW
Arch Otolaryngol Head Neck Surg; 2001 Nov; 127(11):1319-24. PubMed ID: 11701067
[TBL] [Abstract][Full Text] [Related]
9. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
10. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma.
Mattijssen V; De Mulder PH; De Graeff A; Hupperets PS; Joosten F; Ruiter DJ; Bier H; Palmer PA; Van den Broek P
Ann Oncol; 1994 Dec; 5(10):957-60. PubMed ID: 7696170
[TBL] [Abstract][Full Text] [Related]
12. Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma.
Liu S; Yang H; Liang C
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):323-6. PubMed ID: 12408755
[TBL] [Abstract][Full Text] [Related]
13. Effect of suicide gene therapy in combination with immunotherapy on antitumour immune response & tumour regression in a xenograft mouse model for head & neck squamous cell carcinoma.
Ambade AV; Joshi GV; Mulherkar R
Indian J Med Res; 2010 Oct; 132():415-22. PubMed ID: 20966520
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer.
Nemunaitis J; Khuri F; Ganly I; Arseneau J; Posner M; Vokes E; Kuhn J; McCarty T; Landers S; Blackburn A; Romel L; Randlev B; Kaye S; Kirn D
J Clin Oncol; 2001 Jan; 19(2):289-98. PubMed ID: 11208818
[TBL] [Abstract][Full Text] [Related]
15. [Studies of mouse interleukin-2 gene therapy for head, and neck sequamous cell carcinoma using polycationic liposome-mediated transduction].
Yang H; Liu S; Liang C; Peng W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):9-11, 30. PubMed ID: 15600166
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
[TBL] [Abstract][Full Text] [Related]
17. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation.
van Herpen CM; van der Voort R; van der Laak JA; Klasen IS; de Graaf AO; van Kempen LC; de Vries IJ; Boer TD; Dolstra H; Torensma R; van Krieken JH; Adema GJ; De Mulder PH
Int J Cancer; 2008 Nov; 123(10):2354-61. PubMed ID: 18729197
[TBL] [Abstract][Full Text] [Related]
19. [Combined interleukin-2 and herpes simplex virus thymidine kinase gene therapy for head and neck squamous cell carcinoma].
Liu S; Liang C; Yang H; Xian J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):426-9. PubMed ID: 12761956
[TBL] [Abstract][Full Text] [Related]
20. [The effect of IL-2 injection around the metastatic cervical lymphnode].
Ogasawara H; Takeda N; Takeda N; Kumoi T
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1119-22. PubMed ID: 2398297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
